DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MINERAL OIL
4
Small molecule
Unknown
Unknown
Unknown
Skin Diseases; Constipation; Diaper Rash
Unknown
MINERAL OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
T5L8T28FGP
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DARUNAVIR HYDRATE
4
Unknown
Approved
Unknown
ORAL
Unknown
Unknown
DARUNAVIR HYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SISOMICIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial 70S ribosome inhibitor
SISOMICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
X55XSL74YQ
Molecule Type:
Small molecule
Molecular Formula:
C19H37N5O7
Molecular Weight:
447.53
AlogP:
-3.85
PSA:
213.72
HBD:
8.0
HBA:
#RotB:
6.0
Source:
SODIUM TANSHINONE IIA SULFONATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM TANSHINONE IIA SULFONATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIRARUBICIN
4
Small molecule
Approved
Unknown
Unknown
Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma; Breast Neoplasms; Carcinoma, Hepatocellular; Neoplasms
Unknown
PIRARUBICIN
×
Maximum Phase:
4
First Approval:
None
UNII:
D58G680W0G
Molecule Type:
Small molecule
Molecular Formula:
C32H37NO12
Molecular Weight:
627.64
AlogP:
1.55
PSA:
204.3
HBD:
5.0
HBA:
#RotB:
7.0
Source:
BROMELAINS
4
Unknown
Approved
Unknown
Unknown
Neoplasms; Skin Ulcer
Unknown
BROMELAINS
×
Maximum Phase:
4
First Approval:
None
UNII:
U182GP2CF3
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC 99M ARCITUMOMAB
4
Antibody
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM TC 99M ARCITUMOMAB
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUTICASONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUTICASONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AGOMELATINE
4
Small molecule
Approved
Unknown
Unknown
Obsessive-Compulsive Disorder; Anxiety; Dementia; Depressive Disorder, Major; Schizophrenia; Depressive Disorder
Melatonin receptor agonist
AGOMELATINE
×
Maximum Phase:
4
First Approval:
None
UNII:
137R1N49AD
Molecule Type:
Small molecule
Molecular Formula:
C15H17NO2
Molecular Weight:
243.31
AlogP:
2.53
PSA:
38.33
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DIAMMINE SILVER FLUORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DIAMMINE SILVER FLUORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DIPHENHYDRAMINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATAZANAVIR SULFATE; COBICISTAT
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ATAZANAVIR SULFATE; COBICISTAT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZITHROMAX
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ZITHROMAX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TANDOSPIRONE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TANDOSPIRONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EVENING PRIMROSE OIL
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
EVENING PRIMROSE OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IPODATE CALCIUM
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
IPODATE CALCIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
50S7W5M9ZZ
Molecule Type:
Small molecule
Molecular Formula:
C24H24CaI6N4O4
Molecular Weight:
1233.98
AlogP:
3.74
PSA:
52.9
HBD:
1.0
HBA:
#RotB:
5.0
Source:
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
EPINEPHRINE BITARTRATE; LIDOCAINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLOROQUINE PHOSPHATE; PRIMAQUINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RANELIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
RANELIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
K9CCS0RIBT
Molecule Type:
Small molecule
Molecular Formula:
C12H10N2O8S
Molecular Weight:
342.29
AlogP:
-0.08
PSA:
176.23
HBD:
4.0
HBA:
#RotB:
8.0
Source:
TAUROLIDINE
4
Small molecule
Approved
Unknown
Unknown
Central Nervous System Neoplasms; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Infections
Unknown
TAUROLIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8OBZ1M4V3V
Molecule Type:
Small molecule
Molecular Formula:
C7H16N4O4S2
Molecular Weight:
284.36
AlogP:
-2.67
PSA:
98.82
HBD:
2.0
HBA:
#RotB:
2.0
Source:
REBOXETINE
4
Small molecule
Approved
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity; Depressive Disorder, Major; Diabetic Neuropathies; Pain; Anxiety; Dementia; Fibromyalgia; Schizophrenia; Depressive Disorder
Norepinephrine transporter inhibitor
REBOXETINE
×
Maximum Phase:
4
First Approval:
None
UNII:
947S0YZ36I
Molecule Type:
Small molecule
Molecular Formula:
C19H23NO3
Molecular Weight:
313.4
AlogP:
3.19
PSA:
39.72
HBD:
1.0
HBA:
#RotB:
6.0
Source:
EMEPRONIUM BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
EMEPRONIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
WZM699L2TL
Molecule Type:
Small molecule
Molecular Formula:
C20H28BrN
Molecular Weight:
362.36
AlogP:
4.69
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
6.0
Source:
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
4
Protein
Unknown
Unknown
Unknown
Kidney Diseases; Anemia; Renal Insufficiency, Chronic
Erythropoietin receptor agonist
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
×
Maximum Phase:
4
First Approval:
None
UNII:
LR3UXN0193
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIAMTHAZOLE DIHYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DIAMTHAZOLE DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
3LF09TBB5W
Molecule Type:
Small molecule
Molecular Formula:
C15H25Cl2N3OS
Molecular Weight:
366.36
AlogP:
3.08
PSA:
28.6
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
METHYLPREDNISOLONE ACETATE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPOETIN ALFA-EPBX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
EPOETIN ALFA-EPBX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ADALIMUMAB-ADBM
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ADALIMUMAB-ADBM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIOVANCE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BIOVANCE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINOPYRINE
4
Small molecule
Approved
Unknown
Unknown
Fever; Pain
Unknown
AMINOPYRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
01704YP3MO
Molecule Type:
Small molecule
Molecular Formula:
C13H17N3O
Molecular Weight:
231.3
AlogP:
1.55
PSA:
30.17
HBD:
0.0
HBA:
#RotB:
2.0
Source:
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
272
273
274
275
276
277
278
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA